Engineered Biomarkers for Point‐of‐Care Diagnostics

Early diagnosis is essential for managing diseases and improving patient outcomes. Traditional diagnostic biomarkers are often limited by inadequate sensitivity and specificity, vulnerability to external influences, and difficulties in early‐stage detection. Engineered biomarkers that integrate bioengineering, chemistry, and nanotechnology can amplify detection signals by exploiting disease‐associated characteristics. This approach overcomes the limitations of traditional biomarkers and enables early disease diagnosis. Combining point‐of‐care (POC) platforms with engineered biomarkers offers rapid results for timely medical decision‐making. Additionally, the portability of POC platforms enables their use in various settings, including clinics, emergency rooms, and homes, enhancing accessibility for patients in remote areas or those with limited mobility. This platform can also streamline the detection process and reduce the complexity of traditional diagnostic procedures. This review explores the latest design advancements and applications of engineered biomarkers for various diseases from the perspective of POC detection methods. It thoroughly examines how these biomarkers improve the sensitivity and specificity of diagnostic techniques, the challenges of clinical transformation, and future research directions. This article aims to inspire the development of more advanced POC detection platforms for engineered biomarkers, promoting their application in future disease diagnostics and advancing personalized medicine.

• Publication year

  2025

• Venue

  Advanced Healthcare Materials

• Publication date

  2025-11-10

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/adhm.202503581PMID 41208483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pan-PTM profiling identifies post-translational modifications associated with exceptional longevity and preservation of skeletal muscle function in Drosophila

  2025cited by this paper
• Metabolically Stable Chimeric Nucleic Acid Nanoprobe Artificial Biomarker for Cancer Urine Biopsy.

  2025cited by this paper
• Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging

  2025cited by this paper
• Universal Artificial Urinary Biomarker Probe Enabled by an Aptamer-DNAzyme-Nanozyme Construct.

  2025cited by this paper
• Urinary bioorthogonal reporters for the monitoring of the efficacy of chemotherapy for lung cancer and of associated kidney injury

  2025cited by this paper
• Harnessing Nanomaterials for Next-Generation DNA Methylation Biosensors.

  2025cited by this paper
• Artificial biomarker-based feedback-regulated personalized and precise thrombolysis with lower hemorrhagic risk

  2025cited by this paper
• Multi-omics approaches for understanding gene-environment interactions in noncommunicable diseases: techniques, translation, and equity issues

  2025cited by this paper
• Bifunctional Nanoassembly Enables Metabolism-Driven Microfluidic Blood Screening Guided by MRI Localization for Cancer Monitoring.

  2025cited by this paper
• Rapid, Sensitive Detection of Protein Biomarkers in Minimally‐Processed Blood Products with a Monolithic Sandwich Immunoassay Reagent

  2025cited by this paper
• An enzymatic cleavage-triggered minimally invasive nanosensor for urine-based detection of early atherosclerosis

  2025cited by this paper
• Sucrose-Powered Liposome Nanosensors for Urinary Glucometer-Based Monitoring of Cancer.

  2024cited by this paper
• A comprehensive review of machine learning techniques for multi-omics data integration: challenges and applications in precision oncology.

  2024cited by this paper
• Cancer Biomarkers - Emerging Trends and Clinical Implications for personalized treatment

  2024cited by this paper
• Ingestible Artificial Urinary Biomarker Probes for Urine Test of Gastrointestinal Cancer

  2024cited by this paper
• Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers

  2024cited by this paper
• Artificial urinary biomarker probes for diagnosis

  2024cited by this paper
• Renal Clearable Chiral Manganese Oxide Supraparticles for In Vivo Detection of Metalloproteinase‐9 in Early Cancer Diagnosis

  2024cited by this paper
• Towards Next Generation Protein Sequencing

  2024cited by this paper
• Non-invasive in vivo sensing of bacterial implant infection using catalytically-optimised gold nanocluster-loaded liposomes for urinary readout

  2024cited by this paper
• Innovative diagnostic technologies: navigating regulatory frameworks through advances, challenges, and future prospects.

  2024cited by this paper
• Toward High-Quality Real-World Laboratory Data in the Era of Healthcare Big Data

  2024cited by this paper
• Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease

  2024cited by this paper
• Emerging methods and techniques for cancer biomarker discovery.

  2024cited by this paper
• Integrated multi-omics with machine learning to uncover the intricacies of kidney disease

  2024cited by this paper
• SOX17-mediated immune evasion in early colorectal cancer: From pre-malignant adaptation to tumor progression

  2024cited by this paper
• Graph machine learning for integrated multi-omics analysis

  2024cited by this paper
• Emerging trends in organ-on-a-chip systems for drug screening

  2023cited by this paper
• Recent progress of responsive Raman scattering probes for biosensing and bioimaging

  2023cited by this paper
• Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation

  2023cited by this paper
• Imaging and monitoring of granzyme B in the immune response.

  2023cited by this paper
• A dual-responsive crimson fluorescent probe for real-time diagnosis of alcoholic acute liver injury.

  2023cited by this paper
• Artificial Urinary Biomarkers for Early Diagnosis of Acute Renal Allograft Rejection.

  2023cited by this paper
• Size-Transformable Superoxide-Triggered Nanoreporters for Crosstalk-Free Dual Fluorescence/Chemiluminescence Imaging and Urinalysis in Living Mice.

  2023cited by this paper
• Global burden of hematologic malignancies and evolution patterns over the past 30 years

  2023cited by this paper
• Noninvasive Early Diagnosing of Allograft Rejection by a Granzyme B Protease Responsive NIR-II Bioimaging Nanosensor.

  2023cited by this paper
• Biomarker Detection in Early Diagnosis of Cancer: Recent Achievements in Point-of-Care Devices Based on Paper Microfluidics

  2023cited by this paper
• Ultrasensitive Urinary Diagnosis of Organ Injuries Using Time-Resolved Luminescent Lanthanide Nano-bioprobes.

  2023cited by this paper
• Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk assessment, Early Detection, and Prevention.

  2023cited by this paper
• Five-year cancer survival by stage at diagnosis in Canada.

  2023cited by this paper
• Current Trends and Challenges in Point-of-care Urinalysis of Biomarkers in Trace Amounts

  2022cited by this paper
• Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development.

  2022cited by this paper
• Glycosidase activated prodrugs for targeted cancer therapy.

  2022cited by this paper
• Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease.

  2022cited by this paper
• Raman Spectroscopy for Chemical Biology Research

  2022cited by this paper
• Novel DNA nanoflower biosensing technologies towards next-generation molecular diagnostics.

  2022cited by this paper
• Nitric oxide signaling in health and disease.

  2022cited by this paper
• The metabolic nature of inflammatory bowel diseases

  2022cited by this paper
• Molecular Visualization of Early‐Stage Acute Kidney Injury with a DNA Framework Nanodevice

  2022cited by this paper
• A Renally Clearable Activatable Polymeric Nanoprobe for Early Detection of Hepatic Ischemia‐Reperfusion Injury

  2022cited by this paper
• Renal clearable polyfluorophore nanosensors for early diagnosis of cancer and allograft rejection

  2022cited by this paper
• Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2

  2022cited by this paper
• Emerging ELISA Derived Technologies for in vitro Diagnostics

  2022cited by this paper
• Meeting the challenges of existential threats through educational innovation: a proposal for an expanded curriculum

  2022cited by this paper
• Hypoxia-Responsive Platinum Supernanoparticles for Urinary Microfluidic Monitoring of Tumors.

  2022cited by this paper
• Early diagnosis with ultrasensitive ELISA.

  2021cited by this paper
• Acute kidney injury

  2021cited by this paper
• Cerebral Venous Thrombosis.

  2021cited by this paper
• Interfacing Biomaterials with Synthetic T Cell Immunity

  2021cited by this paper
• Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.

  2021cited by this paper
• Meeting the Challenges of Existential Threats through Educational Innovation

  2021cited by this paper
• A Promising NIR-II Fluorescent Sensor for Peptide-Mediated Long-term Monitoring of Kidney Dysfunction.

  2021cited by this paper
• Renal-Clearable Molecular Probe for Near-Infrared Fluorescence Imaging and Urinalysis of SARS-CoV-2

  2021cited by this paper
• Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017

  2021cited by this paper
• An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3.

  2021cited by this paper
• Synthetic biomarkers: a twenty-first century path to early cancer detection

  2021cited by this paper
• Spatial omics and multiplexed imaging to explore cancer biology

  2021cited by this paper
• Chronic kidney disease

  2021cited by this paper
• Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters

  2020cited by this paper
• Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring “Universal” Donor T Cells

  2020cited by this paper
• Tutorial: design and fabrication of nanoparticle-based lateral-flow immunoassays

  2020cited by this paper
• Protease circuits for processing biological information

  2020cited by this paper
• Deterioration in liver function after liver‐directed therapy for hepatocellular carcinoma measured by cholate clearance

  2020cited by this paper
• Engineering synthetic breath biomarkers for respiratory disease

  2020cited by this paper
• CRISPR-Cas-amplified urine biomarkers for multiplexed and portable cancer diagnostics

  2020cited by this paper
• A guide to cancer immunotherapy: from T cell basic science to clinical practice

  2020cited by this paper
• Minicircle DNA: The Future for DNA-Based Vectors?

  2020cited by this paper
• Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

  2020cited by this paper
• Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling

  2020cited by this paper
• Synthetic immunity by remote control

  2020cited by this paper
• Cholangiocarcinoma 2020: the next horizon in mechanisms and management

  2020cited by this paper
• Molecular Imaging with Reporter Genes: Has Its Promise Been Delivered?

  2019cited by this paper
• Renal-clearable Macromolecular Reporter for Near-infrared Fluorescence Imaging of Bladder Cancer.

  2019cited by this paper
• Non-invasive early detection of acute transplant rejection via nanosensors of granzyme-B activity

  2019cited by this paper
• Engineered immune cells as highly sensitive cancer diagnostics

  2019cited by this paper
• Hydrogen sulfide stabilizes atherosclerotic plaques in apolipoprotein E knockout mice.

  2019cited by this paper
• Detection platforms for point-of-care testing based on colorimetric, luminescent and magnetic assays: A review.

  2019cited by this paper
• Detection of tumors with fluoromarker‐releasing bacteria

  2019cited by this paper
• The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions

  2019cited by this paper
• Renal clearable catalytic gold nanoclusters for in vivo disease monitoring

  2019cited by this paper
• Volatile Organic Compound (VOC)-Based Probe for Induced Volatolomics of Cancers.

  2019cited by this paper
• Light-mediated iodoperfluoroalkylation of alkenes/alkynes catalyzed by chloride ions: role of halogen bonding.

  2018cited by this paper
• Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention

  2018cited by this paper
• Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

  2018cited by this paper
• Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics.

  2018cited by this paper
• Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine

  2018cited by this paper
• Classification of prostate cancer using a protease activity nanosensor library

  2018cited by this paper
• Diagnosis of Human Immunodeficiency Virus Infection

  2018cited by this paper
• Protease activity sensors noninvasively classify bacterial infections and antibiotic responses

  2018cited by this paper
• Microfluidic fabrication of microparticles for biomedical applications.

  2018cited by this paper

• No citing papers are available for this paper.